4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-18-055385
Director bought 30,000 shares at $18.00 ($540,000)
- Director acquired 74,870 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Humer Franz B · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-10-15 | Purchase : show line 1 in the form | +30,000 | $18.00 | $540,000 | 30,000 | D |
| 2018-10-15 | Conversion : show line 2 in the form | +74,870 | 104,870 | D | ||
| Open-market purchases · 30,000 sh · avg $18.00 · $540,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-15 | Conversion : show line 3 in the form Series A Convertible Preferred Stock | −14,261 | 0 | D |
Loading xslF345X03/doc4.xml…